| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |